(Q36341821)

13 August 2017

1 reference

title

Therapeutic apheresis--state of the art in the year 2005. (English)

1 reference

13 August 2017

Thomas Bosch

1

1 reference

13 August 2017

publication date

1 December 2005

1 reference

Therapeutic Apheresis and Dialysis

13 August 2017

published in

1 reference

13 August 2017

volume

9

1 reference

13 August 2017

issue

6

1 reference

13 August 2017

page(s)

459-468

1 reference

Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Plasmapheresis in immune hematology: review of clinical outcome data with respect to evidence-based medicine and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Apheresis technologies and clinical applications: the 2002 international apheresis registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Extracorporeal immunoadsorption with protein A: technical aspects and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Immunoadsorption, current status and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Peptide based adsorbers for therapeutic immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Lipidfiltration--safe and effective methodology to perform lipid-apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Blood purification therapies using dextran sulfate cellulose columns Liposorber and Selesorb

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Extracorporeal blood purification in severe liver failure with the albumin dialysis MARS -- impact on relevant intensive care parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Prometheus--a new extracorporeal system for the treatment of liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Plasma exchange conditioning for ABO-incompatible renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Efficacy and safety of DALI-LDL-apheresis in two patients treated with the angiotensin II-receptor 1 antagonist losartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Efficacy and safety of a new whole-blood low-density lipoprotein apheresis system (Liposorber D) in severe hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

State of the art of low-density lipoprotein apheresis in the year 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2005.00306.X

Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Indications for low-density lipoprotein apheresis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

State of the art of lipid apheresis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Immunoglobulin binding properties of the Prosorba immunadsorption column in treatment of rheumatoid arthritis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

LDL-Therasorb immunoadsorption for the treatment of severe hypercholesterolemia refractory to conventional therapy

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Therapeutic apheresis for neurological diseases

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1744-9987.2005.00306.X

Identifiers

DOI

10.1111/J.1744-9987.2005.00306.X

1 reference

13 August 2017

1 reference